Key numeric takeaways from peer-reviewed work: CJC-1295 (long-acting): half-life 5.88.1 days
Enhanced mood and cognitive function : Supports mental clarity, memory, and overall mood improvement
MKH analysed, evaluated and interpreted the data
Significance was determined by one-way repeated measures analysis of variance, and the HolmSidak method for multiple comparisons versus the control group, using SigmaPlot 10.0 software (Systat Software, San Jose, CA, USA)
Specifically, the FDA moved away from aggressive enforcement postures on several key peptides that had been in regulatory limbo: BPC-157 (Body Protection Compound): Removed from the "Category 2" substances list that had restricted its use in compounded medications TB-500 (Thymosin Beta-4 fragment): Similar de-prioritization of enforcement actions against compounding pharmacies MOTS-C : Continued research status maintained without new restrictions This doesn't mean these peptides are FDA-approved drugs
